A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodkin Lymphoma (HL) in Adults Age 60 and Above
Disease Types
Lymphoma
Available at
Bethesda, Brandywine, Clinton, Columbia, Frederick, Rockville, Silver Spring, Wheaton
Contact
Linda Iovanni
MOHRSCH@usoncology.com